Key result
iNOS and eNOS inhibition decreased sweating and cutaneous vasodilation respectively in younger adults exercising in the heat (P<0.05), but iNOS inhibition had no effect in older adults (P>0.05).
Why the study?
Does inhibition of specific NOS isoforms alter sweating and cutaneous vasodilation in younger and older adults exercising in the heat?
Does inhibition of specific NOS isoforms alter sweating and cutaneous vasodilation in younger and older adults exercising in the heat?
iNOS and eNOS are the primary contributors to NOS-dependent sweating and cutaneous vasodilation in younger adults exercising in the heat, but these mechanisms are diminished in older adults.
Answers are grounded in this paper and cite their sources.
NOS inhibition attenuates sweating during exercise in younger adults; extends thermoregulatory mechanisms but leaves open isoform-specific roles in aging.
Nitric oxide synthase (NOS) contributes to sweating and cutaneous vasodilation during exercise in younger adults. We hypothesized that endothelial NOS (eNOS) and neuronal NOS (nNOS) mediate NOS-dependent sweating, whereas eNOS induces NOS-dependent cutaneous vasodilation in younger adults exercising in the heat. Further, aging may upregulate inducible NOS (iNOS), which may attenuate sweating and cutaneous vasodilator responses. We hypothesized that iNOS inhibition would augment sweating and cutaneous vasodilation in exercising older adults. Physically active younger (n = 12, 23 ± 4 yr) and older (n = 12, 60 ± 6 yr) adults performed two 30-min bouts of cycling at a fixed rate of metabolic heat production (400 W) in the heat (35°C). Sweat rate and cutaneous vascular conductance (CVC) were evaluated at four intradermal microdialysis sites with: 1) lactated Ringer (control), 2) nNOS inhibitor (nNOS-I, NPLA), 3) iNOS inhibitor (iNOS-I, 1400W), or 4) eNOS inhibitor (eNOS-I, LNAA). In younger adults during both exercise bouts, all inhibitors decreased sweating relative to control, albeit a lower sweat rate was observed at iNOS-I compared with eNOS-I and nNOS-I sites (all P < 0.05). CVC at the eNOS-I site was lower than control in younger adults throughout the intermittent exercise protocol (all P < 0.05). In older adults, there were no differences between control and iNOS-I sites for sweating and CVC during both exercise bouts (all P > 0.05). We show that iNOS and eNOS are the main contributors to NOS-dependent sweating and cutaneous vasodilation, respectively, in physically active younger adults exercising in the heat, and that iNOS inhibition does not alter sweating or cutaneous vasodilation in exercising physically active older adults.
No takes yet. Share an insight, caveat, or question.
Fujii et al. (2015) studied Healthy adults (n=24). NOS inhibitors (nNOS-I, iNOS-I, eNOS-I) vs. Lactated Ringer (control) was evaluated on Sweat rate and cutaneous vascular conductance (p=<0.05). iNOS and eNOS inhibition decreased sweating and cutaneous vasodilation respectively in younger adults exercising in the heat (P<0.05), but iNOS inhibition had no effect in older adults (P>0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: